Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

Nova MD review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

A $175/mo semaglutide, $199/mo tirzepatide compounded option carrying its own FDA warning letter (September 2025) for a 'same active ingredient as Wegovy & Ozempic' claim the FDA called misleading.

$175/mo
Flat price · every dose
Consult Medication Shipping
See plans at Nova MD
  • Confirm HSA / FSA coverage
  • Public information reviewed
  • Confirm your total cost
Compare alternatives ↓

Nova MD at a glance

Semaglutide
$175/mo
Tirzepatide
$199/mo
Coverage
Not disclosed — no published state list
Brand-name
Compounded only

How we scored Nova MD

Every factor comes from Nova MD's own published pricing, disclosures and oversight, and the six combine into the 28/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance10/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit12/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs28/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost58/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support32/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness48/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

Semaglutide: $175/mo; tirzepatide: $199/mo. Quarterly semaglutide costs $387; quarterly tirzepatide varies by pharmacy, with one listed option temporarily paused.

Before you sign up

What Nova MD's public site and signup page show before you hand over any details.

Worth knowing

  • No monthly price is visible on the public homepage; the number appears only after you begin the intake

Pricing

MedicationPricePlan
Compounded semaglutide$1751-month billing, no commitment$175/mo. Quarterly semaglutide costs $387; quarterly tirzepatide varies by pharmacy, with one listed option temporarily paused.
Compounded tirzepatide$1991-month billing, no commitment$199/mo. Quarterly semaglutide costs $387; quarterly tirzepatide varies by pharmacy, with one listed option temporarily paused.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Nova MD's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • Both molecules available at a mid-range flat price
  • Fast, described 5-minute intake reviewed same-day, no live-video requirement found
  • No separate membership fee mentioned
  • The 3-month prepay tier is disclosed on the same page as the standard rate

The caveats

  • Carries its own FDA warning letter for a misleading 'same active ingredient' claim
  • No published state list
  • Nothing addresses PCOS, postpartum timing, or breastfeeding
  • Compounded only — no FDA-approved brand-name option

This Nova has its own regulatory record

Nova MD at Nova MD's website is separate from Nova at Nova MD's website. Nova MD's operator is JM Health Group LLC, while the other service identifies NovaCure LLC. The FDA warning letter to Try Nova, numbered 716695 and dated September 9, 2025, identifies Nova MD's website. That domain match matters: the letter should remain attached to this service rather than transferred to another company sharing the Nova name. Read the operator and website when evaluating either offer.

The FDA cited false or misleading claims suggesting equivalence with approved products, including a statement about the same active ingredient as Wegovy and Ozempic. The regulatory concern is more specific than a general objection to a low price or to online prescribing. A prospective patient should ask how the service describes the actual compounded preparation now proposed. A familiar ingredient does not make a compounded prescription FDA approved or establish equivalence to an approved branded medicine.

Current monthly prices differ from quarterly purchases

Nova MD lists compounded semaglutide at $175 per month and compounded tirzepatide at $199 on one-month arrangements. Quarterly semaglutide costs $387, an average of $129 across the three-month purchase. That lower equivalent is not the amount payable for one flexible month. Request the complete amount collected, supply schedule, and renewal conditions before choosing a longer term. The difference matters if you want to assess the clinical relationship before committing more money.

Quarterly tirzepatide choices vary by pharmacy, and one listed option has been temporarily paused. Do not assume every advertised pharmacy package is currently available at your address or that another option has the same price. Ask which exact preparation can be supplied, what the full charge buys, and how a change affects a pending purchase. The ordinary $199 monthly figure also needs confirmation for the dose and quantity the clinician actually prescribes.

A short intake is not the whole care relationship

The company describes an approximately five-minute online questionnaire with same-day physician review. Those are service estimates, not guarantees that every application is approved or medication arrives the same day. No mandatory video requirement is established in the published process. If you prefer a scheduled discussion, ask whether one is available and how it is billed. If care begins asynchronously, establish how more complicated questions reach the clinician after the initial review.

A complete state list is not publicly available. Confirm eligibility where you will attend care and receive medication rather than assuming national availability from the website. Also identify the assigned medical practice, clinician, and actual dispensing pharmacy. The existence of pharmacy-dependent packages makes that last point particularly important. The product label should clearly state ingredients, concentration, quantity, storage, and instructions; a prior prescription from elsewhere should not be used to infer those details.

Put the written agreement beside the price

Nova MD does not describe a substantive public pathway for pregnancy planning, breastfeeding, postpartum timing, or PCOS. Relevant history requires a direct clinical conversation and coordination with existing providers. A no-separate-membership description does not establish that every additional visit or service is included. Ask for the full delivered bill and the process for changing or stopping treatment, including any deadline before another order becomes nonrefundable.

Nova MD may appeal to someone who wants a one-month purchase or a pharmacy-specific quarterly alternative. Its own FDA letter and lack of a public service-area list are material considerations alongside the prices. Obtain a clear recurring quote, identified care partners, and cancellation and refund terms before joining. The useful decision keeps the $175 and $199 monthly offers separate from prepaid averages, while preserving the exact regulatory attribution rather than confusing this company with the other Nova service.

The bottom line for mothers

Best for: A mother who reads the FDA letter first and still wants a straightforward, no-membership compounded option at a mid-range price.

Alternatives to Nova MD

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • Bodybuilding Health+ does the disclosure part better than most of this market and the branding part more loosely. It names four compounding pharmacies outright with phone numbers, and it names two lead physicians with their NPI numbers — both of whom check out as active MDs in the federal registry. Pricing is flat at every dose and public before any intake: $179 a month for compounded semaglutide and $209 for tirzepatide, dropping to about $142 and $175 only if you buy a bundle up front. The looser part is the name. The operator is Dynamo Group LLC of Boca Raton, not Bodybuilding.com, and the 'trusted by millions since 1999' line on the page is the licensor's heritage rather than the clinic's. It's compounded-only, so there's no FDA-approved Wegovy or Zepbound route, the bundle discounts come with no published refund terms, and a prominent '4.8 (200+ reviews)' badge sits above a Trustpilot widget whose rating we could not confirm.

    Visit Bodybuilding Health+
  • $197/mo semaglutide and $297/mo tirzepatide, everything included — medication, physician consult, supplies and shipping — compounded in the USA with no hidden fees. No state list is published anywhere we could find.

    Visit RNK Health

Providers like Nova MD

Keep comparing Nova MD

Nova MD, answered

Does Nova MD have an FDA warning letter?
Yes — the FDA sent Try Nova a warning letter dated September 9, 2025, over the claim 'Same active ingredient as Wegovy & Ozempic,' which the FDA said implies equivalence to the FDA-approved product and called misbranding.
What does Nova MD cost?
$175/mo for 'Compounded GLP-1' (semaglutide) on 1-month billing, or $199/mo for 'Compounded GLP-1 + GIP' (tirzepatide). Both drop on a 3-month prepay ($125/$169) — a prepay discount, not the standard rate.

Pricing, states and verification reflect Nova MD's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers